Sandoz celebrates milestone in expanding access to innovative treatments across Europe

Sandoz, a global leader in generic and biosimilar medicines, is pleased to announce the European Commission's (EC) approval of Pyzchiva® (biosimilar us...

April 22, 2024 | Monday | News
SK pharmteco Partners with Ferring Pharmaceuticals to Scale Up Production of ADSTILADRIN® Gene Therapy

Biopharmaceutical contract manufacturer SK pharmteco commits to production, testing, and release of Ferring’s U.S. approved ADSTILADRIN® ...

April 18, 2024 | Thursday | News
Bio-Rad to Invest in Oncocyte for Exclusive Global Transplant Monitoring Technology, Eyeing FDA Clearance and Market Expansion

Bio-Rad expects to make equity investment in support of deal - Agreement provides for global exclusivity in transplant monitoring commercialization - Bio-R...

April 12, 2024 | Friday | News
Bayer and Google Cloud Collaborate on New Innovation Platform to Enhance Radiology with AI Solutions, Alleviating Burnout and Improving Patient Care

Bayer and Google Cloud announced a groundbreaking collaboration aimed at revolutionizing radiology through the development of innovative artificial intelli...

April 10, 2024 | Wednesday | News
Charles River Labs Partners with Axovia to Advance Gene Therapies for Ciliopathies

Charles River Laboratories International, Inc. (NYSE: CRL) today announced a plasmid DNA contract development and manufacturing organization (CDMO) collabo...

April 09, 2024 | Tuesday | News
Sartorius and TheWell Bioscience Partner to Enable More Accurate Predictions in Drug Discovery

Collaboration to advance TheWell Bioscience animal-free hydrogel solutions for 3D cell models Solutions address shift from animal-based to more human-re...

April 09, 2024 | Tuesday | News
Hartwig Medical Foundation and Ultima Genomics Partner to Enhance Cancer Genomic Profiling

-Hartwig Medical Foundation, a pioneer in deploying complete genomic profiling to improve oncology outcomes, and Ultima Genomics, a developer of a revoluti...

April 08, 2024 | Monday | News
Standard BioTools Partners with Bristol Myers Squibb to Utilize SomaScan® Platform in Multi-Year Clinical Trials Engagement

Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ –...

April 04, 2024 | Thursday | News
Agilent Technologies and UC San Diego to Establish Center of Excellence in Cellular Intelligence

Agilent Technologies , a global leader in life sciences, diagnostics, and applied chemical markets, and the University of California San Diego (UC Sa...

April 03, 2024 | Wednesday | News
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

  Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company specializing in allosteric modulation-based drug development,...

April 03, 2024 | Wednesday | News
Function Oncology and Volastra Therapeutics Form Strategic Partnership to Enhance Precision Cancer Treatment

-Function Oncology, a company transforming the operating system of precision medicine with CRISPR-powered platform technology, today announced an innovativ...

March 27, 2024 | Wednesday | News
Biocytogen Partners with ABL Bio to Forge Ahead in Bispecific Antibody-Active Ingredient Conjugate Development

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotechnology company focused on the development of novel antibody the...

March 26, 2024 | Tuesday | News
Gilead Sciences Completes Acquisition of CymaBay, Strengthening Liver Disease Therapies

    “The acquisition of CymaBay brings us a potential best-in-disease therapy that could transform the treatment landscape for people wit...

March 25, 2024 | Monday | News
XRP Healthcare Collaborates with Isansys Lifecare to Transform Healthcare in Uganda

  Isansys Lifecare, led by the visionary Keith Errey, has gained recognition in the global healthcare technology market, particularly through its suc...

March 25, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close